The shared lifecycle of a monoamine neurotransmitter
Serotonin, dopamine, and noradrenaline are the classical monoamine neurotransmitters. Each follows a similar lifecycle. It is synthesized from an amino acid precursor (tryptophan for serotonin, tyrosine for dopamine and noradrenaline), packaged into vesicles, and released into the synapse on an action potential. After acting on receptors it is cleared, mostly by reuptake transporters back into the releasing neuron, then either repackaged or broken down by enzymes such as monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT).
Where modulators act on the cycle
Each step is a potential target. Reuptake transporters are the site for SSRIs and many stimulants, MAO is the target of MAO-inhibitor drugs, and receptor subtypes are targets for many other agents. Adaptogenic and nootropic supplements are generally proposed to act more gently and indirectly on this system, for example by influencing precursor availability, enzyme activity, or receptor sensitivity, rather than blocking a transporter outright.
Drug-supplement interactions on monoamine pathways can be serious, including serotonin syndrome when serotonergic agents are combined. This is general educational information, not medical advice. Anyone taking antidepressants or other psychiatric medication should consult a qualified professional before adding supplements that touch these pathways.